-
Featured Authors
Archive
- September 2016 (3)
- August 2016 (5)
- July 2016 (2)
- June 2016 (6)
- January 2016 (1)
- October 2015 (1)
- September 2015 (1)
- August 2015 (1)
- July 2015 (1)
- June 2015 (1)
- May 2015 (1)
- March 2015 (2)
- February 2015 (1)
- January 2015 (2)
- December 2014 (1)
- November 2014 (1)
- September 2014 (1)
- August 2014 (3)
- July 2014 (1)
- June 2014 (1)
- May 2014 (1)
- April 2014 (1)
- February 2014 (3)
- January 2014 (2)
- December 2013 (2)
- November 2013 (1)
- October 2013 (1)
- September 2013 (2)
- August 2013 (2)
- July 2013 (1)
- April 2013 (1)
- February 2013 (4)
- January 2013 (2)
- December 2012 (1)
- November 2012 (2)
- October 2012 (2)
- August 2012 (1)
- July 2012 (2)
- June 2012 (2)
- May 2012 (1)
- April 2012 (1)
- March 2012 (1)
- December 2011 (1)
- August 2011 (2)
- July 2011 (1)
- June 2011 (5)
- May 2011 (1)
- March 2011 (1)
- February 2011 (1)
- January 2011 (2)
- December 2010 (1)
- November 2010 (2)
- October 2010 (1)
- September 2010 (1)
- August 2010 (1)
- July 2010 (2)
- May 2010 (1)
- April 2010 (1)
- March 2010 (2)
- February 2010 (6)
- January 2010 (1)
- November 2009 (2)
- October 2009 (2)
- September 2009 (1)
- August 2009 (2)
- July 2009 (3)
- June 2009 (2)
- May 2009 (6)
- March 2009 (1)
Category Archives: Jim’s Corner
Welcome to San Diego!
Welcome to the 2014 BIO International Convention. It has been an exciting and important year for our industry. Since we last met, we have seen record IPOs, important new approvals, exciting scientific advances and hard fought policy victories in Washington, DC and the states. But we all know that accomplishments don’t just happen by luck. They are the result of decades of hard work, long hours and repeated setbacks. So while it’s important to celebrate Read More >
BIO CEO Lays out Vision for Future of Industrial Biotech
During the opening plenary lunch at BIO’s World Congress on Industrial Biotechnology, Jim Greenwood, President and CEO of BIO, laid out a comprehensive state of the industry to a packed room of entrepreneurs, scientists, investors and business leaders from more than 35 countries. In his remarks, Greenwood talked about the important strides the industry has made. “Cellulosic and advanced biofuel companies are at a pivotal point in commercial development,” Greenwood said. “In addition, we are Read More >
BIO and Biominas Brasil to Co-Host 2014 BIO Latin America Conference
I am excited to announce that BIO will co-host a new conference event, BIO Latin America, taking place September 9-11, 2014, in Rio de Janeiro, Brazil. We recently entered into an agreement with Biominas Brasil, a not-for- profit institution dedicated to life sciences in the region, to build on the successful BioPartnering Latin America event held by Biominas the past four years. This new international conference for BIO will complement our global portfolio of industry events. The decision Read More >
Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas
In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act: “Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay Read More >
Biotech Investors, Emerging Companies Bullish On 2014
The 16th BIO CEO & Investor Conference is off to a great start. This event has truly grown into a must attend for emerging companies and investors. This year, we have more than 1,300 participants, including more than 850 investors. In addition, we have helped to set up more than 1,700 partnering meetings for participants over the course of the conference. Our world-class partnering system, and the opportunity to hear from key industry leaders, is Read More >
